1. American Cancer Society, Inc. (2007) Leading sites of new cancer cases and deaths-2007 estimates. surveillance research 2007. Available online: http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf Site accessed November 11, 2007
2. Attele AS, Wu JA, Yuan CS (1999) Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685–1693. DOI: 10.1016/S0006-2952(99)00212-9
3. Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, Lumey LH (2002) Chemoprevention strategies for prostate cancer. Eur J Cancer Prev 11 (Suppl 2): S18–S27
4. Cheng CC, Yang SM, Huang CY, Chen JC, Chang WM, Hsu SL (2005) Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol 55: 531–540. DOI: 10.1007/s00280-004-0919-6
5. Cho SD, Jiang C, Malewicz B, Dong Y, Young CY, Kang KS, Lee YS, Ip C, Lu J (2004) Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther 3: 605–611